Contract Services Clinical Research

Novotech Launches Early Phase Unit for Biotechs in Australian and New Zealand Clinical Environment

Novotech, the global full-service Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and n...

 June 14, 2024 | News

IQVIA Launches One Home for Sites™ to Streamline Clinical Trial Management

IQVIA announced the launch of One Home for Sites™, a new technology platform that acts as a single sign-on and a single dashboard for the key systems...

 June 13, 2024 | News

I-Mab Partners with Bristol Myers Squibb for Phase 1 Clinical Trial of Novel Cancer Therapy

I-Mab , a U.S.-based, global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapi...

 June 06, 2024 | News

Syngene Launches Advanced Protein Production Platform Leveraging ExcellGene Technology

Syngene International , a leading global contract research, development and manufacturing organization (CRDMO), announces the launch of its new protein pro...

 June 05, 2024 | News

Thermo Fisher Scientific Launches Advanced Solutions to Boost Research Efficiency at ASMS Conference

Thermo Fisher Scientific has introduced new solutions aimed at accelerating research workflows, unveiled at the annual American Society for Mass Spectromet...

 June 04, 2024 | News

AstraZeneca’s TAGRISSO® Shows Significant Improvement in Progression-Free Survival in Phase III LAURA Trial for EGFR-Mutated NSCLC

Positive results from the LAURA Phase III trial showed AstraZeneca’s TAGRISSO® (osimertinib) demonstrated a statistically significant a...

 June 03, 2024 | News

Metabolon Enhances Metabolomics Services with New Spectral Data Option

Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic developme...

 May 29, 2024 | News

HanAll Biopharma Secures Exclusive Rights to Cutting-Edge Aging Reprogramming Technology

Exclusive agreement allows HanAll to utilize Epigenetic Reprogramming of Aging (ERATM) technology for ophthalmic and otic diseases. Collaboration aims t...

 May 29, 2024 | News

NUS Scientists Discover Novel Method to Activate Muscle Cells’ Natural Defences Against Cancer Using Magnetic Pulses

A team of researchers led by Associate Professor Alfredo Franco-Obregón from the NUS Institute for Health Innovation & Technology (iHealthtech) ...

 May 22, 2024 | News

Duoning Biotechnology and Bioelectronica Announce Strategic Partnership to Transform Antibody Discovery

Duoning Biotechnology Group ("Duoning"), a leading one-stop bioprocess provider in China, today announced a strategic partnership with Bioelectronica,...

 May 21, 2024 | News

Amplexd Therapeutics Secures $2 Million in Strategic Funding to Advance Non-Invasive Treatments for HPV-Induced Cervical Precancers

Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in acc...

 May 20, 2024 | News

Allucent Secures $25.5 Million Award for Decentralized COVID-19 Trial

 Allucent, a global mid-sized clinical research organization (CRO), announced  that it received a project award valued at $25.5 million...

 May 16, 2024 | News

Mabwell Advances Clinical Study of Nectin-4-Targeting ADC for Triple-Negative Breast Cancer

Mabwell, an innovation-driven biopharmaceutical company with entire industry chain, announced the progress of the clinical study of its novel Nectin-4-targ...

 May 14, 2024 | News

Touchlight Genetics and NPL Receive Innovate UK Funding for Advanced Gene Therapy Technology

Touchlight Genetics, in partnership with the National Physical Laboratory (NPL) have secured funding from Innovate UK under their Innovative Technologies: ...

 May 13, 2024 | News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in